Mersedeh Miraliakbari Pharmd, Rph

Mersedeh Miraliakbari has extensive work experience in the pharmaceutical industry. Mersedeh is currently the Senior Vice President of Regulatory Affairs and Quality at Upstream Bio. Prior to this, they held various leadership positions at Nabriva Therapeutics plc, including Senior Vice President of Global Regulatory Affairs and Vice President of Regulatory Affairs.

Before joining Nabriva Therapeutics, Miraliakbari worked at Johnson & Johnson as the Director of Global Regulatory Affairs and Director of Regulatory Affairs Franchise. Mersedeh also has experience in academia, where they worked as a faculty member at the University of Delaware's Clinical Trial Management Certification program.

Miraliakbari has also worked at Teva Pharmaceuticals as the Global Regulatory Affairs Lead and Director of Regulatory Affairs, specializing in CNS drugs, and at AstraZeneca Pharmaceuticals as the Wilmington RAM Director and Group Manager for Global Regulatory Affairs.

Earlier in their career, Miraliakbari gained clinical experience as a Clinical Pharmacist at Main Line Health and as a Pharmacy Manager at Rite Aid Pharmacy. In these roles, they provided clinical information, consulted with healthcare professionals, and ensured quality customer relations.

Overall, Miraliakbari has a strong background in regulatory affairs and quality management, with experience in both industry and academia.

Mersedeh Miraliakbari, PharmD, RPh, obtained a Doctorate degree in Pharmacy from Temple University School of Pharmacy from 1990 to 1999. Additionally, they received a Bachelor's Degree in Pharmacy from Temple University between 1991 and 1994. In terms of additional certifications, Mersedeh Miraliakbari obtained a Certification of Appreciation from the FDA's Office of Generic Drugs in August 1999. In February 2011, they became a member of the Regulatory Affairs Certification Program and obtained the RAPS (Regulatory Affairs Professional Society) membership.